The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial AG Marson, AM Al-Kharusi, M Alwaidh, R Appleton, GA Baker, ... The Lancet 369 (9566), 1016-1026, 2007 | 1131 | 2007 |
Quality of life of people with epilepsy: a European study GA Baker, A Jacoby, D Buck, C Stalgis, D Monnet Epilepsia 38 (3), 353-362, 1997 | 1096 | 1997 |
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial AG Marson, AM Al-Kharusi, M Alwaidh, R Appleton, GA Baker, ... The Lancet 369 (9566), 1000-1015, 2007 | 1069 | 2007 |
Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs KJ Meador, GA Baker, N Browning, J Clayton-Smith, DT Combs-Cantrell, ... New England journal of medicine 360 (16), 1597-1605, 2009 | 968 | 2009 |
The clinical course of epilepsy and its psychosocial correlates: findings from a UK community study A Jacoby, GA Baker, N Steen, P Potts, DW Chadwick Epilepsia 37 (2), 148-161, 1996 | 894 | 1996 |
Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study KJ Meador, GA Baker, N Browning, MJ Cohen, RL Bromley, ... The Lancet Neurology 12 (3), 244-252, 2013 | 893 | 2013 |
Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures … WC LaFrance Jr, GA Baker, R Duncan, LH Goldstein, M Reuber Epilepsia 54 (11), 2005-2018, 2013 | 811 | 2013 |
The longer term outcome of children born to mothers with epilepsy N Adab, U Kini, J Vinten, J Ayres, G Baker, J Clayton-Smith, H Coyle, ... Journal of Neurology, Neurosurgery & Psychiatry 75 (11), 1575-1583, 2004 | 729 | 2004 |
Epilepsy and social identity: the stigma of a chronic neurological disorder A Jacoby, D Snape, GA Baker The Lancet Neurology 4 (3), 171-178, 2005 | 690 | 2005 |
The stigma of epilepsy: a European perspective GA Baker, J Brooks, D Buck, A Jacoby Epilepsia 41 (1), 98-104, 2000 | 541 | 2000 |
Predictors of health‐related quality of life and costs in adults with epilepsy: a systematic review RS Taylor, JW Sander, RJ Taylor, GA Baker Epilepsia 52 (12), 2168-2180, 2011 | 455 | 2011 |
Outcomes of add‐on treatment with lamotrigine in partial epilepsy D Smith, G Baker, G Davies, M Dewey, DW Chadwick Epilepsia 34 (2), 312-322, 1993 | 436 | 1993 |
The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs RL Bromley, GE Mawer, M Briggs, C Cheyne, J Clayton-Smith, ... Journal of Neurology, Neurosurgery & Psychiatry 84 (6), 637-643, 2013 | 422 | 2013 |
Psychogenic non-epileptic seizures—definition, etiology, treatment and prognostic issues: a critical review NMG Bodde, JL Brooks, GA Baker, P Boon, JGM Hendriksen, OG Mulder, ... Seizure 18 (8), 543-553, 2009 | 417 | 2009 |
Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial FG Gilliam, AJ Fessler, G Baker, V Vahle, J Carter, H Attarian Neurology 62 (1), 23-27, 2004 | 394 | 2004 |
In utero antiepileptic drug exposure: fetal death and malformations KJ Meador, GA Baker, RH Finnell, LA Kalayjian, JD Liporace, DW Loring, ... Neurology 67 (3), 407-412, 2006 | 377 | 2006 |
Patients' experiences of injury as a result of epilepsy D Buck, GA Baker, A Jacoby, DF Smith, DW Chadwick Epilepsia 38 (4), 439-444, 1997 | 374 | 1997 |
Autism spectrum disorders following in utero exposure to antiepileptic drugs RL Bromley, G Mawer, J Clayton-Smith, GA Baker, ... Neurology 71 (23), 1923, 2008 | 341 | 2008 |
IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study GA Baker, RL Bromley, M Briggs, CP Cheyne, MJ Cohen, ... Neurology 84 (4), 382-390, 2015 | 315 | 2015 |
Factors influencing compliance with antiepileptic drug regimes D Buck, A Jacoby, GA Baker, DW Chadwick Seizure 6 (2), 87-93, 1997 | 311 | 1997 |